Zobrazeno 1 - 10
of 37
pro vyhledávání: '"A. B. Kushnir"'
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 5, Pp 28-32 (2024)
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an orphan disease of the peripheral nervous system. The clinical phenotypes of CIDP may influence the choice of primary pathogenetic therapy. In some cases, viral infection may be a trigger
Externí odkaz:
https://doaj.org/article/e2c6cbe24a6e409fb1dd740585a822fd
Autor:
Ilya I. Ustenko, Yana B. Kushnir, Alexandr V. Amelin, Andrey А. Gotovchikov, Denis V. Goranchuk, Alexander N. Kulikov
Publikováno v:
Клиническая практика, Vol 13, Iss 1, Pp 107-117 (2022)
Background: The study analyzes a possible rare complication of COVID-19 in the form of spondylodiscitis, including that followed by epiduritis, in patients who survived COVID-19 characterized by severe pneumonia, respiratory failure and systemic infl
Externí odkaz:
https://doaj.org/article/918b7eab6d834832b2c09abcfb3ba9be
Autor:
Vasyl B. Kushnir
Publikováno v:
Східноукраїнський медичний журнал, Vol 9, Iss 4, Pp 362-372 (2021)
Introduction. In Ukraine, despite the free medical care in the field of tuberculosis, the effectiveness of tuberculosis treatment does not meet WHO standards. With the lack of resistance of Mycobacterium tuberculosis to the first-line anti-TB agents,
Externí odkaz:
https://doaj.org/article/3306889b515e4963a7589281029836b0
Autor:
Ya. B. Kushnir, N. M. Tereshchenko, M. P. Abramova, A. A. Gotovchikov, A. Yu. Polushin, V. S. Krasnov
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 28, Iss 2, Pp 17-22 (2021)
Currently, due to the lack of specific etiotropic therapy, rituximab is widely used for the treatment of most autoimmune diseases of the central and peripheral nervous system. Rituximab is a chimeric monoclonal antibody with specificity for CD20, the
Externí odkaz:
https://doaj.org/article/c4f16b06ad8441d0a220786f7968cbe3
Autor:
A. N. Moshnikova, V. K. Maksimchuk, S. V. Lapin, V. D. Nazarov, E. A. Surkova, S. A. Novikov, G. S. Makshakov, I. Yu. Krutetskaya, V. S. Krasnov, Ya. B. Kushnir, N. A. Neofidov, N. A. Totolian, A. A. Skoromets, E. P. Evdoshenko, Areg A. Totolian
Publikováno v:
Инфекция и иммунитет, Vol 9, Iss 5-6, Pp 703-712 (2020)
Multiple sclerosis is chronic demyelinating disease of the central nervous system with autoimmune inflammation and accretive neurodegeneration. One of the characteristics of autoimmune inflammation in multiple sclerosis is a polyspecific intrathecal
Externí odkaz:
https://doaj.org/article/6c3d14a17f2a4c6ba344cb2e4b7914c4
Autor:
N. M. Tereshchenko, Ya. B. Kushnir, M. P. Abramova, A. A. Gotovchikov, V. S. Krasnov, A. Y. Sokolov, N. A. Totolyan, A. V. Amelin
Publikováno v:
Bulletin of Siberian Medicine. 22:174-182
Aim. To describe best practices in using human normal immunoglobulin in patients with immune-mediated neurological disorders according to the data of one clinical center.Materials and methods. From 2016 to 2021, 20 patients with various autoimmune di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::208f6d78fb62a49ee96ba1bc58ab8660
https://doi.org/10.20538/1682-0363-2023-1-174-182
https://doi.org/10.20538/1682-0363-2023-1-174-182
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 25, Iss 3, Pp 7-13 (2018)
Neuromyelitis optica spectrum disorder (NMOSD) is an aggregate of inflammatory and autoimmune disorders of the central nervous system characterized by recurrent, disabling clinical course and damages predominantly targeting optic nerves, brain stem a
Externí odkaz:
https://doaj.org/article/4d6eb518293a4e7784db5900254b4acc
Publikováno v:
Human Physiology. 48:656-666
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eea91b9bb800453e89ac763c42053f4
https://doi.org/10.1134/s036211972260028x
https://doi.org/10.1134/s036211972260028x
Autor:
C. C. Cherebillo, V. D. Nazarov, Y. M. Kiryanov, C. V. Lapin, A. V. Mazing, N. V. Shuleshova, G. S. Makshakov, N. A. Totolyan, Y. B. Kushnir, A. V. Cupaeva, V. D. Piven, V. L. Emanuel
Publikováno v:
Russian neurological journal. 27:32-42
Introduction. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is one of the most common genetic causes of small-vessel cerebral diseases.Objective. The aim of our study was to examine the frequency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21edf3d90e9abdea9c770ec7b4d15445
https://doi.org/10.30629/2658-7947-2022-27-1-32-42
https://doi.org/10.30629/2658-7947-2022-27-1-32-42
Autor:
V. S. Krasnov, Ya. B. Kushnir, M. P. Abramova, N. M. Tereshchenko, A. A. Gotovchikov, A. Yu. Polushin
Publikováno v:
Učenye Zapiski Sankt-Peterburgskogo Gosudarstvennogo Medicinskogo Universiteta im. Akad. I.P. Pavlova, Vol 28, Iss 2, Pp 17-22 (2021)
Currently, due to the lack of specific etiotropic therapy, rituximab is widely used for the treatment of most autoimmune diseases of the central and peripheral nervous system. Rituximab is a chimeric monoclonal antibody with specificity for CD20, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d21cc70c8e2765da5afdb4423fb23b
https://doi.org/10.24884/1607-4181-2021-28-2-17-22
https://doi.org/10.24884/1607-4181-2021-28-2-17-22